Mark Sherry, Ph.D. Associate Professor of Sociology, has developed a series of YouTube videos to support his teaching (particularly for online classes) and discuss books that his students are studying.
Below is one of these videos in which he discusses
“DES Daughters – Embodied Knowledge and the Transformation of Women’s Health Politics“
a book by Susan E. Bell
The social action component of research and how DES activists forced medicine to change, how DES victims got together to force a federal task force to look into the DES issues and how a national registry was developed to record DES health issues
“My name is Penny Oliver and I am committed to creating artwork that will inspire and reinvigorate you in your practice of medicine. By interpreting and translating anatomic, histologic and diagnostic images, I seek to create art that is both beautiful to the layperson and meaningful to the medical professional. Contact me to see how your work and passion can be transformed into a stunning piece of original art.” – Diagnosis ART, Custom Paintings for the Medical Professional
Images copyrightDiagnosis Art – All rights reserved.
“The watercolors and drawings,Surviving DES are a response to being a DES baby. My mother was given a drug, diethylstilbestrol, when she was pregnant with me. I have health issues as the result. The women who were given this drug between the 1940′s through the late 1970′s were actually being experimented on by the drug companies. These paintings and drawings, are my positive response to a negative situation. My art is my catharsis.”
Archival footage from late 1980s with Attorney Stephen Sheller, P.C. on AM Philadelphia which brings the DES matter to people’s attention and acknowledges the devastating side effects of this drug on women and men and over three generations.
One of the first worldwide drug scandal is DES (Diethylstilbestrol) affecting millions of people in countries where the anti miscarriage drug was widely prescribed to pregnant women decades ago. You may have been exposed to DES without knowing it! The time bomb effects and associated health issues on three generations are still being ignored.
Titre originel: “Effets transgénérationnels des perturbateurs endocriniens: les leçons du DES”
Intervention du Dr Annie J. Sasco, Médecin épidémiologiste du cancer, sur le thème “Effets transgénérationnels des perturbateurs endocriniens: les leçons du DES” lors de la table-ronde organisée par WECF le 10 avril sur le thème “Perturbateurs endocriniens, effets et mécanismes d’action de la conception à la maturité”.
Pour plus d’information sur la journée tenue à l’Assemblée Nationale le 10 Avril 2012 vous pouvez lire cet article: Les Perturbateurs Endocriniens publié le 26 Avril dernier.
On Tuesday 10th April 2012, the French National Assembly hosted a debate around the harmful effects of endocrine disruptors to convince governments to take action. French and foreign Endocrine Disruptors (ED) specialists attended the event, gave presentations and discussed the many issues associated with ED. Among them was Dr. Annie J. Sasco , Cancer epidemiologist, INSERM Research Director, University of Bordeaux, France, who worked on the transgenerational effects of endocrine disruptors, more specifically those of DES: “I am very pessimistic. For 30 years, cancer has doubled in the world. The DES tragedy is not enough. Even though DES was registered in 1939 in Britain on the poisons’ list, and it had been proven it was ineffective for the prevention of miscarriage since 1953, nothing prevented this drug from being widely produced and prescribed. It has been recognized as a carcinogenic drug since 1974, and it is now proven to have effects on the third generation in terms of risk of cancer, including ovarian and genital malformation rate 18 times higher than normal. We’ve just banned Bisphenol A in baby bottles yet the risks were known since the 30s. Another example is hormone replacement therapy: its extended use to 10 years of treatment is associated with an increased risk of cancer. “
You can find more information about this debate by reading this article published on April, 26th (approximate translation by Google).
From Maryland – Exposure to Diethylstilbestrol in the womb raises a woman’s risk of many cancers, according to a report published in the New England Journal of Medicine. Researchers studied over 6500 women, 4600 of whom were exposed to DES in the womb. Results showed that this exposure significantly increased risk of many cancers and fertility problems, including a 40x increased risk of clear-cell adenocarcinoma, 8x increased risk of neonatal death, 2.4x increased risk of infertility and a 1.8x increased risk of breast cancer.
Susan Helmrich is one of the best swimmers in the world in her age group. She’s also a three-time cancer survivor and a victim of one of the greatest drug tragedies in history. With luck, determination, great medical care, the support of family and friends and the benefits of the sport of swimming, Susan has fought to escape the deadly legacy of a supposed wonder drug turned nightmare.
Take a Survcast Surv™ about Susan’s video and DES…
=> – video from benzestrol.
Back in the 1950′s and 1960′s, doctors were the target for most drug advertising campaigns including DES.
Drug companies supplied hundreds of doctors with samples to give to their female patients, thus creating a market for the drug (in the case of diethylstilbestrol even before it was approved by the FDA).
Somehow DES set the template of “How To” market a dangerous drug to women. In 1948, diethylstilbestrol was advertised as the “Wonder Drug” recommended for all pregnancies. The face of a cherubic infant grinned up from the pages of medical journals next to the caption: “Really? Yes, desPLEX to prevent abortion, miscarriage and premature labor…bigger and stronger babies“.
As early as 1953, research revealed that DES did not work – that DES actually brought about higher rates of premature birth and infant mortality – yet DES continued to be prescribed to pregnant women for decades mainly because pharmaceutical companies continued to heavily promote DES use to doctors and most doctors relied on the drug companies and their sales representatives for information.
